Dave Turkaly

You called out some tuck-in M&A in Healthcare and then obviously, $1 billion buyback. I was just wondering should we be reading into that at all in terms of sizable transactions

I know it's not a big component, but the capital component. I was wondering if you could just give us any color as to what was going on there in the fourth quarter

the biggest implied delta is then at LifeSci. And I was just curious to get some color on your comfort in that kind of bouncing back

It seems like the tariff impact might be, I don't know, $0.24 or something like that on the EPS line, yet you're still getting into double-digit range

it seems like there's a shift kind of towards that, you know, even towards the mid to higher single digit